The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)
Clinical trial NCT03197870 · COMPLETED
Trial details
- NCT number
- NCT03197870
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-09
- Primary completion
- 2019-01-09
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.